Feature Channels: Vaccines

Filters close

Not for public release

This news release is embargoed until 25-Nov-2024 5:00 PM EST Released to reporters: 19-Nov-2024 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 25-Nov-2024 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: New Research Could Pave Way for Vaccine Against Deadly Wildlife Disease
Released: 19-Nov-2024 3:35 PM EST
New Research Could Pave Way for Vaccine Against Deadly Wildlife Disease
Michigan State University

Sean Crosson, a Professor Rudolph Hugh Endowed Chair in Michigan State University’s Department of Microbiology, Genetics and Immunology, has been awarded a $2.4 million grant from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases to study the cause of that very disease, Brucella abortus.

Newswise: 1920_1920-vaccine-cedars-sinai.jpg?10000
Released: 18-Nov-2024 11:10 AM EST
Cómo Mantener a los Mayores Fuera del Hospital Durante la Temporada de la Gripe
Cedars-Sinai

La influenza puede ser una enfermedad desagradable de una semana de duración y un inconveniente para muchas personas, pero puede tener consecuencias graves para los adultos mayores.

Newswise: Argonne to Explore Novel Ways to Fight Cancer and Transform Vaccine Discovery with Over $21 Million From ARPA-H
Released: 14-Nov-2024 2:35 PM EST
Argonne to Explore Novel Ways to Fight Cancer and Transform Vaccine Discovery with Over $21 Million From ARPA-H
Argonne National Laboratory

Argonne has received up to $21 million from ARPA-H to use AI and supercomputing in two projects: one targeting hard-to-treat tumors, and another aiming to create vaccines for multiple viral threats, including cancer and pandemics.

Released: 13-Nov-2024 10:25 PM EST
Community Partners Key to Success of Vaccine Clinic Focused on Neurodevelopmental Conditions
UC Davis MIND Institute

Community partnerships led to a specialized clinic delivering COVID and flu shots to individuals with neurodevelopmental conditions like autism at the MIND Institute.

Newswise: Vaccine Shows Promise Against Aggressive Breast Cancer
11-Nov-2024 12:10 PM EST
Vaccine Shows Promise Against Aggressive Breast Cancer
Washington University in St. Louis

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors. Conducted at Washington University School of Medicine in St. Louis with a therapy designed by WashU Medicine researchers, the trial is the first to report results for this type of vaccine — known as a neoantigen DNA vaccine — for breast cancer patients.

Released: 13-Nov-2024 1:15 PM EST
Un avance hacia medicamentos y vacunas inhalables de ARNm
American Chemical Society (ACS)

A la mayoría de la gente no le gusta aplicarse vacunas o inyecciones para recibir tratamientos. Por eso, los investigadores trabajan para crear más medicamentos, como los que se fabrican a partir de ARN mensajero (ARNm), que puedan pulverizarse e inhalarse. Un estudio publicado en la revista Journal of the American Chemical Society informa sobre los avances para hacer posible los medicamentos de ARNm inhalables. Los investigadores indican que la nanopartícula de polímero lipídico, que es estable cuando se nebuliza y libera aerosoles (gotitas líquidas) en los pulmones de ratones de forma satisfactoria, se optimizó para contener el ARNm.

   
8-Nov-2024 8:00 AM EST
An Advance Toward Inhalable mRNA Medications, Vaccines
American Chemical Society (ACS)

A study in the Journal of the American Chemical Society reports steps toward making inhalable mRNA medicines a possibility. Researchers outline their improved lipid-polymer nanoparticle for holding mRNA that is stable when nebulized and successfully delivers aerosols (liquid droplets) in mice’s lungs.

   
Newswise: Lab-Grown Human Immune System Uncovers Weakened Response in Cancer Patients
Released: 12-Nov-2024 2:55 PM EST
Lab-Grown Human Immune System Uncovers Weakened Response in Cancer Patients
Georgia Institute of Technology

These miniature immune system models — known as human immune organoids — mimic the real-life environment where immune cells learn to recognize and attack harmful invaders and respond to vaccines. Not only are these organoids powerful new tools for studying and observing immune function in cancer, their use is likely to accelerate vaccine development, better predict disease treatment response for patients, and even speed up clinical trials.

Released: 12-Nov-2024 10:10 AM EST
USU Researchers Develop Highly Effective Chlamydia Vaccine
Uniformed Services University of the Health Sciences (USU)

Researchers from Uniformed Services University of the Health Sciences and Duke University have developed a promising vaccine offering strong protection against chlamydia. The study, published in npj Vaccines, shows that a whole-cell vaccine protected mice from infections, helping them clear the bacteria faster and with fewer infections, potentially reviving debates on chlamydia prevention.

Newswise: World Pneumonia Day, Nov. 12:  2.2 Million Lives Lost to Pneumonia in 2021
Released: 12-Nov-2024 9:25 AM EST
World Pneumonia Day, Nov. 12: 2.2 Million Lives Lost to Pneumonia in 2021
American Thoracic Society (ATS)

Urgent action is needed, to prevent pneumonia deaths among high-risk groups, particularly children younger than five years and older people, noted the American Thoracic Society and its Forum of International Respiratory Societies (FIRS) partners. New effective preventive interventions are available, but these are still inaccessible in many low- and middle-income countries (LMICs).

Newswise: Cleveland Clinic Announces Updated Findings in Preventive Breast Cancer Vaccine Study
Released: 8-Nov-2024 10:25 AM EST
Cleveland Clinic Announces Updated Findings in Preventive Breast Cancer Vaccine Study
Cleveland Clinic

Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease. The study team found that the investigational vaccine was generally well tolerated and produced an immune response in most patients. The team described the side effects of the vaccine, showed the highest tolerated dose to date, and presented the immunologic effects of the vaccine. Findings are being presented at the Society for Immunotherapy of Cancer Annual Meeting.

Newswise: Number of Whooping Cough Cases on Rise Nationally
Released: 8-Nov-2024 9:15 AM EST
Number of Whooping Cough Cases on Rise Nationally
Vanderbilt University Medical Center

Whooping cough is making a comeback, and medical providers say the highly contagious bacterial infection that causes severe coughing fits is preventable. During the COVID-19 pandemic, whooping cough, also known as pertussis, declined dramatically.

Released: 5-Nov-2024 11:20 PM EST
Rutgers Study Reveals Vaccination Patterns Among LGBTQ+ Adults in New Jersey and New York
Rutgers University-New Brunswick

A new study led by Rutgers Health researchers has uncovered important insights into vaccination patterns among LGBTQ+ adults in New Jersey and New York. The findings, published in the journal Vaccine, shed light on disparities in vaccine uptake within this diverse population.

Released: 1-Nov-2024 4:00 PM EDT
Houston Methodist Researchers Shed Light on Increased Rates of Severe Human Infections Caused by Streptococcus Subspecies
Houston Methodist

A concerning increase in global rates of severe invasive infections becoming resistant to key antibiotics has a team of infectious disease researchers at the Houston Methodist Research Institute studying a recently emerged strain of bacteria called Streptococcus dysgalactiae subspecies equisimilis (SDSE). SDSE infects humans via the skin, throat, gastrointestinal tract and female genital tract to cause infections ranging in severity from strep throat (pharyngitis) to necrotizing fasciitis (flesh-eating disease).

Newswise: Steps You Can Take to Reduce Your Risk for Liver Cancer
Released: 1-Nov-2024 10:25 AM EDT
Steps You Can Take to Reduce Your Risk for Liver Cancer
University of Kentucky

Liver cancer is the sixth leading cause of cancer death in the U.S. The most common type of liver cancer in adults is hepatocellular carcinoma, and men are more likely to develop HCC than women. It typically develops in people with long-lasting liver disease caused by hepatitis virus infection or cirrhosis. In many cases, liver cancer is a preventable cancer, so raising awareness about prevention is important.

Released: 30-Oct-2024 12:00 PM EDT
MD Anderson Research Highlights for October 30, 2024
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

   


close
2.74707